Find More Contacts for Sierra Oncology
Protected Content
General Counsel, General Counsel, Compliance
Executive Management
1 email found
View contacts for Sierra Oncology to access new leads and connect with decision-makers.
View All Contacts
  • Contact Email investors@sierraoncology.com
  • Phone Number (604)558-6536

Sierra Oncology is a late-stage biopharmaceutical company on a mission to deliver targeted therapies that treat rare forms of cancer. The company harnesses its deep scientific expertise to identify compounds that target the root cause of disease. Sierra Oncology's team takes an evidence-based approach to understand the limitations of current

treatments and explore new ways to change the cancer treatment paradigm. Sierra Oncology is transforming promise into patient impact.

Lists Featuring This Company

Acquired Silicon Valley Companies
4,289 Number of Organizations â€¢ $129.7B Total Funding Amount â€¢ 13,861 Number of Investors
Closed Health Care Companies (Top 10K)
9,671 Number of Organizations â€¢ $83.6B Total Funding Amount â€¢ 9,079 Number of Investors
Silicon Valley Companies that Exited
4,657 Number of Organizations â€¢ $378.8B Total Funding Amount â€¢ 16,160 Number of Investors
Closed Western US Health Care Companies
2,316 Number of Organizations â€¢ $30.6B Total Funding Amount â€¢ 3,165 Number of Investors
Sierra Oncology merged with GlaxoSmithKline for $1.9B on Apr 13, 2022. This deal was done in Cash.

Frequently Asked Questions

Where is Sierra Oncology's headquarters? Sierra Oncology is located in San Mateo, California, United States.Who invested in Sierra Oncology? Sierra Oncology has 12 investors including Oxford Finance LLC and Frazier Healthcare Partners.How much funding has Sierra Oncology raised to date? Sierra Oncology has raised .When was the last funding round for Sierra Oncology? Sierra Oncology closed its last funding round on Jan 31, 2022 from a Post-IPO Equity round.Who are Sierra Oncology's competitors? Alternatives and possible competitors to Sierra Oncology may include Milestone PharmaceuticalsPassage Bio, and Affimed.